Natural Product: NPC469761

Natural Product IDNPC469761
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
N-[2-(1H-Indol-3-Yl)Ethyl]Tridecan-1-Amine
IUPAC Name N-[2-(1H-indol-3-yl)ethyl]tridecan-1-amine
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1170476
PubChem CID 46897207
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0000183] Tryptamines and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey MHZCNONGJKITGR-UHFFFAOYSA-N
Standard InCHI InChI=1S/C23H38N2/c1-2-3-4-5-6-7-8-9-10-11-14-18-24-19-17-21-20-25-23-16-13-12-15-22(21)23/h12-13,15-16,20,24-25H,2-11,14,17-19H2,1H3
SMILES CCCCCCCCCCCCCNCCC1=CNC2=CC=CC=C21

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   342.3 Volume:   400.699
?
Van der Waals volume.
Dense:   0.854 LogP:   6.166
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.35
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.076
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   10.0
TPSA:   27.82
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   2.0 Rings:   2.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.35 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.013 Fsp3:   0.652
MCE-18:   9.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.894 Fluc inhibitor:   0.002
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.028
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.683
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.145

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.077 MDCK Permeability:   -4.812
Pgp-inhibitor:   0.011 Pgp-substrate:   0.929
PAMPA:   0.002
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.081
20% Bioavailability (F20%):   0.434 30% Bioavailability (F30%):   0.931
50% Bioavailability (F50%):   0.929

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.203 MRP1:   0.942
Plasma Protein Binding (PPB):   97.699% Volume Distribution (VD):   1.433
Fu: 2.364%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.199
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.586
BSEP inhibitor:   0.1

ADMET: Metabolism

CYP1A2-inhibitor:   0.104 CYP1A2-substrate:   0.969
CYP2C19-inhibitor:   0.307 CYP2C19-substrate:   0.002
CYP2C9-inhibitor:   0.899 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.761
CYP3A4-inhibitor:   0.007 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.253 CYP2C8-inhibitor:   0.534
HLM stability:   0.099
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.353 Half-life (T1/2):  0.449

ADMET: Toxicity

hERG Blockers:  0.924 hERG Blockers (10um):  0.95
Human Hepatotoxicity (H-HT):  0.881 Drug-induced Liver Injury (DILI):  0.307
AMES Toxicity:  0.13 Rat Oral Acute Toxicity:  0.626
Maximum Recommended Daily Dose:  0.8 Skin Sensitization:  0.991
Carcinogencity:  0.038 Eye Corrosion:  0.61
Eye Irritation:  0.771 Respiratory Toxicity:  0.998
Drug-induced Neurotoxicity:  0.469 Ototoxicity:  0.391
Hematotoxicity:  0.138 Drug-induced Nephrotoxicity:  0.76
Genotoxicity:  0.001 RPMI-8226 Immunitoxicity:  0.083
A549 Cytotoxicity:  0.669 Hek293 Cytotoxicity:  0.254
BCF:   1.917
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.468
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.273
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.367
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31161 Annonaceae Genus Annonaceae Eukaryota n.a. n.a. n.a. PMID[20579892]
NPO31161 Annonaceae Genus Annonaceae Eukaryota n.a. leaf n.a. PMID[23513739]
NPO31161 Annonaceae Genus Annonaceae Eukaryota n.a. fruit n.a. PMID[26920282]
NPO31161 Annonaceae Genus Annonaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4564 Cell line Neurons n.a. Activity = 92.8 % PMID[22394155]
NPT4564 Cell line Neurons n.a. Activity = 121.2 % PMID[19319825]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 810000.0 nM PMID[20579892]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC469761 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC469780
1.0 High Similarity NPC469783
1.0 High Similarity NPC469766
1.0 High Similarity NPC469779
1.0 High Similarity NPC469768
1.0 High Similarity NPC469784
0.8364 Intermediate Similarity NPC469767
0.8113 Intermediate Similarity NPC469785
0.6531 Remote Similarity NPC84911
0.5932 Remote Similarity NPC609408
0.5918 Remote Similarity NPC96102
0.5893 Remote Similarity NPC609424
0.5306 Remote Similarity NPC601214
0.5094 Remote Similarity NPC29886
0.5079 Remote Similarity NPC218268
0.5079 Remote Similarity NPC469760
0.5079 Remote Similarity NPC469786

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469761 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5918 Remote Similarity NPD198 Clinical (unspecified phase)
0.5517 Remote Similarity NPD1722 Phase 4
0.537 Remote Similarity NPD786 Pre-clinical

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data